Perspective: Regulatory Agencies' Changes to Testosterone Product Labeling

E-ISSN： 1743-6109|12|8|1690-1693

ISSN： 1743-6095

Source： THE JOURNAL OF SEXUAL MEDICINE, Vol.12, Iss.8, 2015-08, pp. : 1690-1693

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Changes to Pregnancy and Lactation Risk Labeling for Prescription Drugs

NURSING FOR WOMENS HEALTH, Vol. 19, Iss. 3, 2015-06 ,pp. : 266-270

John Wiley & Sons Inc

Access to resources Recommend Favorite

Corpora Cavernosa Histological Changes in Testosterone Deficiency

Current Urology, Vol. 4, Iss. 2, 2010-05 ,pp. : 57-61

Karger

Access to resources Recommend Favorite

Good publication practice guidelines for medical communications agencies: a MedComm perspective*

By Bareket-Samish A. Denny M. Ruzicka B. Bogush M. Flynn K. Glinka K. McMahon-Wise B. Schiller S. Sjostedt P. Matheson N.

Current Medical Research and Opinion, Vol. 25, Iss. 2, 2009-02 ,pp. : 453-461

Informa Healthcare

Access to resources Recommend Favorite

The Funding Agencies' Perspective on the Provision of Electronic Assistive Technology: Equipping for Life?

By Cowan Donna M Turner-Smith Alan R

The British Journal of Occupational Therapy, Vol. 62, Iss. 2, 1999-02 ,pp. : 75-79

College of Occupational Therapists

Access to resources Recommend Favorite

Labeling

THE BROWN UNIVERSITY PSYCHOPHARMACOLOGY UPDATE, Vol. 26, Iss. 6, 2015-06 ,pp. : 8-8

John Wiley & Sons Inc

Access to resources Recommend Favorite